The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Positive Regulation of Raf1-MEK1/2-ERK1/2 Signaling by Protein Serine/Threonine Phosphatase 2A Holoenzymes
Open accessAbstract
Protein serine/threonine phosphatase 2A (PP2A) regulates a wide variety of cellular signal transduction pathways. The predominant form of PP2A in cells is a heterotrimeric holoenzyme consisting of a scaffolding (A) subunit, a regulatory (B) subunit, and a catalytic (C) subunit. Although PP2A is known to regulate Raf1-MEK1/2-ERK1/2 signaling at multiple steps in this pathway, the specific PP2A holoenzymes involved remain unclear. To address this question, we established tetracycline-inducible human embryonic kidney 293 cell lines for overexpression of FLAG-tagged Balpha/delta regulatory subunits by approximately 3-fold or knock-down of Balpha by greater than 70% compared with endogenous levels. The expression of functional epitope-tagged B subunits was confirmed by the detection of A and C subunits as well as phosphatase activity in FLAG immune complexes from extracts of cells overexpressing the FLAG-Balpha/delta subunit. Western analysis of the cell extracts using phosphospecific antibodies for MEK1/2 and ERK1/2 demonstrated that activation of these kinases in response to epidermal growth factor was markedly diminished in Balpha knock-down cells but elevated in Balpha- and Bdelta-overexpressing cells as compared with control cells. In parallel with the activation of MEK1/2 and ERK1/2, the inhibitory phosphorylation site of Raf1 (Ser-259) was dephosphorylated in cells overexpressing Balpha or Bdelta. Pharmacological inhibitor studies as well as reporter assays for ERK-dependent activation of the transcription factor Elk1 revealed that the PP2A holoenzymes ABalphaC and ABdeltaC act downstream of Ras and upstream of MEK1 to promote activation of this MAPK signaling cascade. Furthermore both PP2A holoenzymes were found to associate with Raf1 and catalyze dephosphorylation of inhibitory phospho-Ser-259. Together these findings indicate that PP2A ABalphaC and ABdeltaC holoenzymes function as positive regulators of Raf1-MEK1/2-ERK1/2 signaling by targeting Raf1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss and gain of B55α and B55δ function in serum-starved HEK cells re-stimulated with EGF confirmed the implication of PP2A/B55 trimeric holoenzymes in MEK1/2 and ERK1/2 activation via RAF1 activation (Adams et al., 2005).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Adams et al., 2005
In the citing paper
“In the MAPK pathway, PP2A/B family members B55α and B55δ dephosphorylate RAF1 on Ser259 (Adams et al., 2005; Ory et al., 2003), a residue that when phosphorylated inhibits RAF1 kinase by binding to 14-3-3 proteins (Abraham et al., 2000; Jaumot and Hancock, 2001).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Adams et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
Widmann, C., Gibson, S. B., Jarpe, M. B., & Johnson, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,707
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/bj3530417 · Cited by 1,392
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zołnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793
Regulation of Raf-1 by direct feedback phosphorylation.
Dougherty, M., Müller, J., Ritt, D. A., Zhou, M., Zhou, X.-Z., Copeland, T., Conrads, T., Veenstra, T., Lu, K., & Morrison, D. (2005) · Molecules and Cells · doi:10.1016/j.molcel.2004.11.055 · Cited by 663
The complexity of Raf-1 regulation
Morrison, D. K., & Cutler, R. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80060-9 · Cited by 636
Sontag, E., Fedorov, S. A., Kamibayashi, C., Robbins, D. J., Cobb, M. H., & Mumby, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90533-v · Cited by 510
Peterson, R., Desai, B. N., Hardwick, J. S., & Schreiber, S. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.8.4438 · Cited by 496
Mechanisms of regulating the Raf kinase family
Kopera, H. C., Vikis, H. G., & Guan, K. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00139-0 · Cited by 404
Flagged first, then by citations
Research works printed but not linked: 3
- Healy, 1991, Mol. Cell. Biol., 11, 5767
- Liu, 2004, Am. J. Physiol., 286, H2204
- Pelech, 2003, 218, 99
Cited by
Sorted by citations
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 814
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Peterson, Y. K., & Luttrell, L. M. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013367 · Cited by 447
PP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 380
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty‐Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 387
Kuo, Y.-C., Huang, K.-Y., Yang, C.-H., Yang, Y.-S., Lee, W.-Y., & Chiang, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709585200 · Cited by 367
Kaileh, M., Berghe, W. V., Heyerick, A., Horion, J., Piette, J. G., Libert, C., Keukeleire, D. D., Essawi, T. A., & Haegeman, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606728200 · Cited by 303
Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2969-07.2007 · Cited by 228
Letourneux, C., Rocher, G., & Porteu, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600980 · Cited by 224
Hales, E. C., Taub, J. W., & Matherly, L. H. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.021 · Cited by 187
Targeting Protein Serine/Threonine Phosphatases for Drug Development
McConnell, J. L., & Wadzinski, B. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053140 · Cited by 175
Maillet, M., Purcell, N. H., Sargent, M. A., York, A. J., Bueno, O. F., & Molkentin, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806085200 · Cited by 172
Feng, Y., Niu, L.-L., Wei, W., Zhang, W.-Y., Li, X.-Y., Cao, J.-H., & Zhao, S.-H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.462 · Cited by 146
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Lou, H., Montoya, S. E., Alerte, T. N. M., Wang, J., Wu, J., Peng, X., Hong, C.-S., Friedrich, E. E., Mader, S. A., Pedersen, C. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100867 · Cited by 115
Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
Giussani, P., Tringali, C., Riboni, L., Viani, P., & Venerando, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034356 · Cited by 116
“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
Cseh, B., Doma, E., & Baccarini, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.025 · Cited by 108
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2019.03.009 · Cited by 93
Rocher, G., Letourneux, C., Lenormand, P., & Porteu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609712200 · Cited by 87
McConnell, J. L., Gomez, R. J., McCorvey, L. R. A., Law, B. K., & Wadzinski, B. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210406 · Cited by 80
ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks
Khalil, A. A., Morgan, R. N., Adams, B. R., Golding, S. E., Dever, S. M., Rosenberg, E., Povirk, L. F., & Valerie, K. C. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14713 · Cited by 80
Batut, J., Schmierer, B., Cao, J., Raftery, L. A., Hill, C. S., & Howell, M. T. (2008) · Development · doi:10.1242/dev.020842 · Cited by 84
PP2A: The Wolf in Sheep’s Clothing?
Bailey‐Whyte, M., & Kiely, P. (2015) · Cancers · doi:10.3390/cancers7020648 · Cited by 82
Zhou, X., Updegraff, B. L., Guo, Y., Peyton, M., Girard, L., Larsen, J. E., Xie, X., Zhou, Y., Hwang, T. H., Xie, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1267-t · Cited by 75
Nunbhakdi‐Craig, V., Schüchner, S., Sontag, J., Montgomery, L. G., Pallas, D. C., Juno, C., Mudrak, I., Ogris, E., & Sontag, E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04503.x · Cited by 72
Endothelial RAF1/ERK activation regulates arterial morphogenesis
Deng, Y., Larrivée, B., Zhuang, Z. W., Atri, D. S., Moraes, F., Prahst, C., Eichmann, A., & Simons, M. (2013) · Blood · doi:10.1182/blood-2012-12-474601 · Cited by 72
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner
Xiao, Z., Carrasco, R., Kinneer, K., Sabol, D., Jallal, B., Coats, S., & Tice, D. A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20080 · Cited by 70
Li, C., Xiao, L., Jia, J., Li, F., Wang, X., Duan, Q., Jing, H., Yang, P., Chen, C., Wang, Q., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.184 · Cited by 68
Hein, A. L., Seshacharyulu, P., Rachagani, S., Sheinin, Y. M., Ouellette, M. M., Ponnusamy, M. P., Mumby, M. C., Batra, S. K., & Yan, Y. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2119 · Cited by 66
Antunes, G., & Schutter, E. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5976-11.2012 · Cited by 64
Protein phosphatase 2A plays a crucial role in Giardia lamblia differentiation
Lauwaet, T., Davids, B. J., Torres-Escobar, A., Birkeland, S. R., Cipriano, M. J., Preheim, S. P., Palm, D., Svärd, S. G., McArthur, A. G., & Gillin, F. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.12.001 · Cited by 66
Lockyer, A. E., Spinks, J. N., Walker, A. J., Kane, R. A., Noble, L. R., Rollinson, D., Dias‐Neto, E., & Jones, C. S. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.11.004 · Cited by 69
Arrestins as Regulators of Kinases and Phosphatases
Luttrell, L. M., & Miller, W. E. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00005-x · Cited by 62
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies
Vera, J., Lartigue, L., Vigneron, S., Gadéa, G., Gire, V., Rio, M. D., Soubeyran, I., Chibon, F., Lorca, T., & Castro, A. (2015) · eLife · doi:10.7554/elife.10115 · Cited by 60
The road to ERK activation: Do neurons take alternate routes?
Zobon, N. T. M., & Blackwell, K. T. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109541 · Cited by 59
Kurimchak, A., & Graña, X. (2012) · Gene · doi:10.1016/j.gene.2012.02.015 · Cited by 58
Diversity in arrestin function
Kendall, R. T., & Luttrell, L. M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0088-1 · Cited by 58
Ma, L., Lan, F., Zheng, Z., Xie, F., Wang, L., Liu, W., Han, J., Zheng, F., Xie, Y., & Huang, Q. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-79 · Cited by 58
Widau, R. C., Jin, Y., Dixon, S. A. H., Wadzinski, B. E., & Gallagher, P. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085076 · Cited by 55
Chuang, M., Wu, S.-T., Tang, S., Lai, X., Lai, H.-C., Hsu, K.-H., Sun, K., Sun, G.-H., Chang, S.-Y., Yü, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073401 · Cited by 54
Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B
Xu, J., Lu, Y., Liu, Q., Xia, A., Zhao, J., Xu, X., Sun, Q., Qi, F., & Sun, B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.032 · Cited by 51
Fritz, A., Brayer, K. J., Mccormick, N., Adams, D. G., Wadzinski, B. E., & Vaillancourt, R. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509249200 · Cited by 50
Hein, A. L., Brandquist, N. D., Ouellette, C. Y., Seshacharyulu, P., Enke, C. A., Ouellette, M. M., Batra, S. K., & Yan, Y. (2019) · Oncogenesis · doi:10.1038/s41389-019-0172-9 · Cited by 46
Dajani, O. F., Meisdalen, K., Guren, T. K., Aasrum, M., Tveteraas, I. H., Lilleby, P., Thoresen, G. H., Sandnes, D., & Christoffersen, T. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21205 · Cited by 46
Kilili, G. K., & Kyriakis, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078915 · Cited by 43
Regulation of Signal Transduction by DJ-1
Oh, S. E., & Mouradian, M. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6583-5_8 · Cited by 44
Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice
Fan, X., Wang, C., Shi, P., Gao, W., Gu, J., Geng, Y., Yang, W., Wu, N., Wang, Y., Xu, Y., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017015149 · Cited by 42
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Wang, P., Laster, K. V., Jia, X., Dong, Z., & Liu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01903-x · Cited by 43
Wu, H., Li, H.-F., Wu, X., Zhao, J., & Guo, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.073 · Cited by 40
Jefcoate, C. R. E., Lee, J., Cherradi, N., Takemori, H., & Duan, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.006 · Cited by 39
The impact of phosphatases on proliferative and survival signaling in cancer
Narla, G., Sangodkar, J., & Ryder, C. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2826-8 · Cited by 39
Xu, T., Lu, R.-F., Romano, D., Pitt, A. R., Houslay, M. D., Milligan, G., & Kölch, W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05770-11 · Cited by 38
Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics
Lee, S., Pant, H. C., & SHEA, T. B. (2014) · Journal of Cell Science · doi:10.1242/jcs.153346 · Cited by 36
Martín-Encabo, S., Santos, E., & Guerrero, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.036 · Cited by 37
Nagasaka, K., Seiki, T., Yamashita, A., Massimi, P., Subbaiah, V. K., Thomas, M., Kranjec, C., Kawana, K., Nakagawa, S., Yano, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053752 · Cited by 35
Kurimchak, A., & Graña, X. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985069 · Cited by 33
Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes
Zang, K., Wang, J., Dong, M., Sun, R., Wang, Y.-X., Huang, Y., Liu, X., Li, Y., Wang, F., & Yu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078536 · Cited by 34
The interaction of SET and protein phosphatase 2A as target for cancer therapy
Dacol, E. C., Wang, S., Chen, Y., & Lepique, A. P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188578 · Cited by 35
Kinases and phosphatases in ischaemic preconditioning: a re-evaluation
Fan, W. J., van Vuuren, D., Genade, S., & Lochner, A. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0086-3 · Cited by 32
Inside-Out Regulation of FcαRI (CD89) Depends on PP2A
Bakema, J. E., Bakker, A., de Haij, S., Honing, H., Bracke, M., Koenderman, L., Vidarsson, G., van de Winkel, J. G. J., & Leusen, J. H. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4080 · Cited by 30
NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway
Lee, M. Y., Jeong, W.-J., Oh, J., & Choi, K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.018 · Cited by 30
Functional importance of PP2A regulatory subunit loss in breast cancer
Watt, L. F., Panicker, N., Mannan, A., Copeland, B., Kahl, R. G. S., Dun, M. D., Young, B., Roselli, S., & Verrills, N. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4403-5 · Cited by 29
Panicker, N., Coutman, M., Lawlor-O’Neill, C., Kahl, R. G. S., Roselli, S., & Verrills, N. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00358 · Cited by 28
Kim, S. H., Seo, M. S., Jeon, W. J., Yu, H. S., Park, H. G., Jung, G.-A., Lee, H. Y., Kang, U. G., & Kim, Y. S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008292 · Cited by 29
Guo, Y., Deng, Y., Li, X., Ning, Y., Lin, X., Guo, S., Chen, M., & Han, M. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162658 · Cited by 29
Mazalouskas, M. D., Godoy‐Ruiz, R., Weber, D. J., Zimmer, D. B., Honkanen, R. E., & Wadzinski, B. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518514 · Cited by 28
Berrou, E., & Bryckaert, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.002 · Cited by 26
Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin
Cavaleri, F. (2018) · International Journal of Inflammation · doi:10.1155/2018/5023429 · Cited by 26
Raf-independent, PP2A-dependent MEK activation in response to ERK silencing
Bae, D., & Ceryak, S. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.082 · Cited by 24
Gilan, O., Diesch, J., Amalia, M., Jastrzebski, K., Chüeh, A. C., Verrills, N. M., Pearson, R. B., Mariadason, J. M., Tulchinsky, E. M., Hannan, R. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.26 · Cited by 24
Zhande, R., Zhang, W., Zheng, Y., Pendleton, E., Li, Y., Polakiewicz, R. D., & Sun, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605251200 · Cited by 24
Pitman, M. R., Barr, R. K., Gliddon, B. L., Magarey, A. M., Moretti, P. A. B., & Pitson, S. M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.11.001 · Cited by 23
Κουτσιούμπα, Μ., Chen, H., O’Brien, N. A., Koinis, F., Mahurkar‐Joshi, S., Vorvis, C., Soroosh, A., Luo, T., Issakhanian, S., Pantuck, A. J., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1049 · Cited by 23
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype
Kashani, E., & Vassella, E. (2022) · Cancers · doi:10.3390/cancers14215227 · Cited by 22
Irie, A., Harada, K., Araki, N., & Nishimura, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051242 · Cited by 23
Wang, F., Zhu, S., Fisher, L. A., Wang, W., Oakley, G. G., Li, C., & Peng, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-21040-6 · Cited by 23
Targeting Tumor Metastasis by Regulating Nm23 Gene Expression
Prabhu, V. V., Siddikuzzaman, S., Grace, V. M. B., & Guruvayoorappan, C. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.8.3539 · Cited by 22
TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection
Girkin, J. L. N., Hatchwell, L., Collison, A., Starkey, M. R., Hansbro, P. M., Yagita∥, H., Foster, P. S., & Mattes, J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00200.2016 · Cited by 22
Santamaría, E., Mora, M. I., Potel, C., Fernández‐Irigoyen, J., Carro-Roldán, E., Hernández-Alcoceba, R., Prìeto, J., Epstein, A. L., & Corrales, F. J. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800202-mcp200 · Cited by 21
Sontag, J., Schuhmacher, D., Taleski, G., Jordan, A., Khan, S. Z., Hoffman, A., Gomez, R. J., Mazalouskas, M. D., Hanks, S. K., Spiller, B. W., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102248 · Cited by 19
Nifoussi, S. K., Ratcliffe, N. R., Ornstein, D. L., Kasof, G. M., Strack, S., & Craig, R. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587873 · Cited by 20
Hsiung, S., Tin, A., Tamir, H., Franke, T. F., & Liu, K. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21676 · Cited by 20
Chen, G., Li, T., Xiao, J., Wang, J., Shang, Q., Qian, H., Qiao, C., Zhang, P., Chen, T., & Liu, X. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02966-8 · Cited by 19
The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease
Aczél, D., György, B., Bakonyi, P., BukhAri, R., Pinho, R. A., Boldogh, I. R., Gu, Y., & Radak, Z. O. (2022) · Antioxidants · doi:10.3390/antiox11051028 · Cited by 19
Callejas‐Valera, J. L., Guinea‐Viniegra, J., Ramírez‐Castillejo, C., Recio, J. A., Galán‐Moya, E. M., Martinez, N. J., Rojas, J. M., y Cajal, S. R., & Sánchez‐Prieto, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709230200 · Cited by 18
Xu, J., Zhang, L., Xu, Y., Zhang, H., Gao, J., Wang, Q., Tian, Z., Lv, X., Chen, H., & Wang, Y. (2019) · Viruses · doi:10.3390/v11100948 · Cited by 17
Takai, M., Nakagawa, T., Tanabe, A., Terai, Y., Ohmichi, M., & Asahi, M. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002362 · Cited by 16
Tsukamoto, T., Hama, S., Kogure, K., & Tsuchiya, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.031 · Cited by 16
Zhao, J., Wu, H., Chen, Y., Tian, H., Li, L., Han, X., & Guo, J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21712 · Cited by 16
Han, J., Xie, Y., Lan, F., Yu, Y., Liu, W., Chen, J., Zheng, F., OUYANG, X., Lin, X., Lin, Y., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2401 · Cited by 16
Kawahara, E., Maenaka, S., Shimada, E., Nishimura, Y., & Sakurai, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063729 · Cited by 16
Montenegro, M. F., Martí-Díaz, R., Navarro, A., Tolivia, J., Sánchez‐del‐Campo, L., Cabezas‐Herrera, J., & Rodríguez‐López, J. N. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06288-9 · Cited by 13
Kranias, G., Watt, L. F., Carpenter, H., Holst, J., Ludowyke, R. I., Strack, S., Sim, A. T. R., & Verrills, N. M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.017 · Cited by 13
Proteomic analysis of talazoparib resistance in triple‐negative breast cancer cells
Eskiler, G. G., Yanar, S., Akpınar, G., & Kasap, M. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22678 · Cited by 11
Zencir, S., Sike, Á., Dobson, M. J., Ayaydin, F., Boros, I., & Topcu, Z. (2012) · Biochemical Journal · doi:10.1042/bj20120452 · Cited by 11
Aguilar‐Valdés, A., Noriega, L. G., Tovar, A. R., Ibarra-Sánchez, M. D. J., Sosa‐Hernández, V. A., Maravillas‐Montero, J. L., & Martínez‐Aguilar, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.018 · Cited by 10
Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System
Peterson, J., McTiernan, C. D., Thome, C., Khaper, N., Lees, S. J., Boreham, D. R., Tai, T. C., & Tharmalingam, S. (2022) · Bioengineering · doi:10.3390/bioengineering9050214 · Cited by 10
Taleski, G., Schuhmacher, D., Su, H. K., Sontag, J., & Sontag, E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016069 · Cited by 10
Isolation and Characterization of PP2A Holoenzymes Containing FLAG-Tagged B Subunits
Adams, D. G., & Wadzinski, B. E. (2007) · Humana Press eBooks · doi:10.1385/1-59745-267-x:101 · Cited by 10
Expanding the spectrum of syndromic PPP2R3C ‐related XY gonadal dysgenesis to XX gonadal dysgenesis
Altunoğlu, U., Börklü, E., Shukla, A., Escande‐Beillard, N., Ledig, S., Azaklı, H., Nayak, S. S., Eraslan, S., Girisha, K. M., Kennerknecht, I., et al. (2021) · Clinical Genetics · doi:10.1111/cge.14086 · Cited by 8
Metadata
- Authors
- Adams, D. G., Coffee, R. L., Zhang, H., Pelech, S., Strack, S., & Wadzinski, B. E.
- Affiliations
- Vanderbilt University Medical Center (US)
- Kinexus Bioinformatics Corporation (Canada) (CA)
- University of British Columbia (CA)
- University of Iowa (US)
- Corresponding author
- Wadzinski, Brian E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 52
- Pages
- 42644-42654
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2055476265
- Cited by
- 133
- References
- 55
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 10 · 2012: 9
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Vanderbilt University (DK20593, CA68485)
- Vanderbilt-Ingram Cancer Center (CA68485)
- National Institutes of Health (CA68485, DK 20593)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Institute of Mental Health (MH19732, T32MH019732)
- National Cancer Institute (CA68485, P30CA068485)
- National Institute of General Medical Sciences (R01GM062265, GM-51366, GM62265)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 20593, T32DK007563)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- Raf-1, MEK1/2, ERK1/2, MAPK signaling, PP2A holoenzyme, epidermal growth factor, Ras
- MeSH terms
- Epitopes, Cell Line, Enzyme Activation, Enzyme Inhibitors, Humans, Luciferases, Phosphoprotein Phosphatases, Phosphorylation, Plasmids, Serine, Tetracycline, Transfection, Immunoblotting, Blotting, Western, Signal Transduction, Gene Expression Regulation, Enzymologic, Dimerization, Proto-Oncogene Proteins c-raf, Mitogen-Activated Protein Kinase 1, Reverse Transcriptase Polymerase Chain Reaction, Catalytic Domain, MAP Kinase Signaling System, RNA Interference, Immunoprecipitation, Mitogen-Activated Protein Kinase 3, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review